Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "Infant Clinical Nutrition - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Infant Clinical Nutrition was estimated at US$31.0 Billion in 2023 and is projected to reach US$43.3 Billion by 2030, growing at a CAGR of 4.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. 
What Is Infant Clinical Nutrition and Its Importance?
Infant clinical nutrition provides medically tailored dietary solutions for infants who have specific health needs, such as those born prematurely or with medical conditions that affect their ability to consume regular infant formula. This specialized nutrition is crucial for the proper growth and development of these infants, offering tailored macronutrient and micronutrient compositions to meet their unique health requirements. The importance of clinical nutrition in early life stages is underscored by the need to support optimal developmental outcomes, particularly in infants who require additional nutritional support to thrive.
How Is the Field of Infant Clinical Nutrition Evolving?
The field of infant clinical nutrition is rapidly evolving with advances in medical and nutritional sciences. Research into the unique nutritional needs of medically fragile infants has led to the development of formulas and feeding solutions that closely mimic human breast milk, which is considered the gold standard for infant nutrition. Innovations include the incorporation of human milk oligosaccharides, which are crucial for immune system development and gut health. Furthermore, the growing understanding of the microbiome's role in early childhood development is influencing product formulations to include prebiotics and probiotics to support gut health and immune function.
What Market Trends Are Driving Demand for Infant Clinical Nutrition?
The market for infant clinical nutrition is driven by several trends, including the increasing incidence of preterm births and the growing awareness and diagnosis of food allergies and metabolic disorders in infants. These trends necessitate specialized dietary formulations to meet the heightened nutritional requirements of these infants. Additionally, healthcare providers and parents are becoming more knowledgeable about the potential long-term health impacts of early nutritional interventions, which is increasing demand for these products. The trend towards personalized medicine is also extending into pediatric nutrition, influencing the development of more targeted and effective nutritional therapies.
Growth in the Infant Clinical Nutrition Market Is Driven by Several Factors
The growth in the infant clinical nutrition market is driven by several factors, including advancements in medical research that enhance understanding of infant nutritional needs and the development of new products that address these needs more effectively. The increasing prevalence of conditions that require specialized nutrition solutions, such as allergies and preterm births, also significantly contributes to market growth. Additionally, global initiatives to improve neonatal care and nutritional outcomes are promoting the use of advanced clinical nutrition products. The rising investment in healthcare infrastructure and services around the world supports the accessibility and adoption of these specialized nutritional solutions, further driving market expansion.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Milk-Based Infant Clinical Nutrition segment, which is expected to reach US$27.2 Billion by 2030 with a CAGR of a 5.4%. The Soy-Based Infant Clinical Nutrition segment is also set to grow at 3.7% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, which was estimated at $8.4 Billion in 2023, and China, forecasted to grow at an impressive 4.5% CAGR to reach $6.7 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 246 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $31 Billion |
| Forecasted Market Value (USD) by 2030 | $43.3 Billion |
| Compound Annual Growth Rate | 4.9% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- Infant Clinical Nutrition - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Economic Update
MARKET TRENDS & DRIVERS
- Rising Awareness of Infant Nutrition Throws the Spotlight on Clinical Nutrition Products
- Increasing Prevalence of Infant Malnutrition Drives Demand for Specialized Nutrition Solutions
- Advancements in Nutritional Science Propel Growth in Infant Clinical Nutrition Market
- Rising Incidence of Preterm Births Expands Addressable Market Opportunity for Infant Clinical Nutrition
- Stringent Regulatory Standards in Infant Nutrition Spur Adoption of Clinically-Tested Products
- Growing Focus on Pediatric Healthcare Strengthens Business Case for Clinical Nutrition Products
- Increasing Investment in Research and Development Generates Opportunities for Innovative Infant Nutrition Solutions
- Emerging Trends in Personalized Nutrition Propel Growth in the Infant Clinical Nutrition Market
- Rising Global Healthcare Expenditure Drives Adoption of High-Quality Clinical Nutrition for Infants
- Increased Emphasis on Immune-Boosting Ingredients in Infant Nutrition Products Drives Market Growth
- Focus on Sustainable and Ethical Sourcing Practices Throws Spotlight on New Product Developments
- Growing Concerns Over Lactose Intolerance and Other Digestive Issues Propel Demand for Alternative Infant Nutrition Solutions
FOCUS ON SELECT PLAYERS (Total 46 Featured)
- Abbott Laboratories
- B. Braun Melsungen AG
- Baxter International, Inc.
- Claris Lifesciences Ltd.
- Fresenius Kabi AG
- Groupe Danone
- Mead Johnson Nutrition Company
- Meiji Co., Ltd.
- Nestle Health Science SA
- Nutricia North America
For more information about this report visit https://www.researchandmarkets.com/r/n5i0vp
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
